Karki, B. (2024) “Clinical response to Rifaximin amongst irritable bowel syndrome (IBS) patients at tertiary level hospital in Nepal”, Journal of Patan Academy of Health Sciences, 11(1), pp. 21–26. doi: 10.3126/jpahs.v11i1.65652.